'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations

Nature Immunology 18, 255 (2017). doi:10.1038/ni.3682 Authors: Eric Tran, Paul F Robbins & Steven A Rosenberg

http://feeds.nature.com/~r/ni/rss/current/~3/Uk7aSheHO7I/ni.3682

Source: Nature Immunology - February 14, 2017 Category: Allergy & Immunology Authors: Eric Tran Paul F Robbins Steven A Rosenberg Tags: Review Source Type: research

More News: Allergy & Immunology | Cancer | Cancer & Oncology | Immunotherapy